FindTrial
Sign In

Clinical efficacy of Daihuangfuzi Decoction with added ingredients on sepsis acute gastrointestinal dysfunction: a randomized controlled trial

Clinical efficacy of Daihuangfuzi Decoction with added ingredients on sepsis acute gastrointestinal dysfunction: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16008800
Enrollment
Unknown
Registered
2016-07-07
Start date
2016-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute gastrointestinal dysfunction

Interventions

The experimental group:The basic treatment plus Daihuangfuzi Decoction with added ingredients
The control group:The basic treatment

Sponsors

Dongfang Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with sepsis; 2. The APACHE II score 1; 4. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Gastrointestinal function disorder caused by primary gastrointestinal diseases; 2. Chinese medicine allergy or gastrointestinal feeding prohibitted; 3. The primary severe gastrointestinal bleeding and gastric retention; 4. Clearly diagnosed by malignant tumor.

Design outcomes

Primary

MeasureTime frame
Gastrointestinal function;APACHEII score;Case fatality rate of 28 day;—

Secondary

MeasureTime frame
WBC;CRP;Intestinal flora;SOFA score;qSOFA score;Gastrointestinal hormone;Blood gas analysis+emergency biochemical;Liver and kidney function;Routine urine;—

Countries

China

Contacts

Public ContactLiu Fusheng

Dongfang Hospital Beijing University of Chinese Medicine

hmzxs217@163.com+86 13401097747

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026